My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Reso 2011-1813
SIBFL
>
City Clerk
>
Resolutions
>
Regular
>
2011
>
Reso 2011-1813
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
12/21/2011 2:41:55 PM
Creation date
12/21/2011 2:41:55 PM
Metadata
Fields
Template:
CityClerk-Resolutions
Resolution Type
Resolution
Resolution Number
2011-1813
Date (mm/dd/yyyy)
12/15/2011
Description
City’s “Drug-Free in Workplace Program Policy”, as Amended
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
45
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
<br />I. Collection Site, Work Site, Personnel <br /> <br />1. A specimen for a drug test will be taken or collected by: <br /> <br />a. A physician, a physician's assistant, a registered professional nurse, a licensed <br />practical nurse, a nurse practitioner, or a certified paramedic who is present at <br />the scene of the accident for the purpose of rendering emergency service or <br />treatment; or <br /> <br />b. A qualified person employed by a licensed laboratory who has the necessary <br />training and skills for the assigned tasks. <br /> <br />2. In the case of a chemical breath test, utilizing evidential breath test devices, a <br />technician licensed pursuant to Rule 100-42, F.A.C. In the case of other reliable <br />mechanisms, a management representative who has received training in <br />administering the test and analyzing the results. <br /> <br />J. Testing Laboratory <br /> <br />1. The laboratory used to analyze initial or confirmation blood or urine specimens will <br />be licensed or certified by the appropriate regulatory agencies to perform such tests. <br />The Florida Department of Health and Rehabilitative Services has published Drug- <br />Free Workplace Standards (Florida Administrative Code, Chapter 10E-18) which <br />shall be followed by laboratories and employers for testing procedures required <br />unders440.101-102, Fla. Stat. (1993). <br /> <br />2. All laboratory security, chain of custody, transporting and receiving of specimens, <br />specimen processing, retesting, storage of specimens, instrument calibration and <br />reporting of results will be in accordance with applicable state or federal laws and <br />rules established by HRS of the U.S. Department of Transportation. <br /> <br />3. The laboratory or Medical Review Officer will provide assistance to the employee or <br />job applicant for the purpose of interpreting any positive confirmed test results. <br /> <br />K. Initial Tests Used for Implementing S 440.101-.102. Fla.Stat. (1993)* <br /> <br />Initial tests will use an immunoassay except that the test for alcohol will be an enzyme <br />oxidation methodology. The following cutoff levels will be used when screening <br />specimens to determine whether they are positive or negative for these drugs or <br />metabolites. All levels equal to or exceeding the following will be reported as positive: <br />. Alcohol .05g/dl% <br />. Amphetamines 1000ng/ml <br />. Cannabinoids 100ng/ml <br />. Cocaine 300ng/ml <br />. Phencyclidine 25ng/ml <br />. Methaqualone 300ng/ml <br />. Opiates 300ng/ml <br />. Barbiturates 300ng/ml <br />. Benzodiazepines 300ng/ml <br />. Synthetic Narcotics: <br />o Methadone <br />o Propoxyphene <br /> <br />300ng/ml <br />300ng/ml <br /> <br />SIB_Drug-Free_ Workplace]rogram_-_ W-CDL <br /> <br />Page 14 of41 <br /> <br />12/15/2011 <br />
The URL can be used to link to this page
Your browser does not support the video tag.